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Abstract
Background: Metabolomics is a rapidly developing functional genomic tool that has a wide range of applications
in diverse fields in biology and medicine. However, unlike transcriptomics and proteomics there is currently no
central repository for the depositing of data despite efforts by the Metabolomics Standard Initiative (MSI) to
develop a standardised description of a metabolomic experiment.
Findings: In this manuscript we describe how the MSI description has been applied to a published dataset
involving the identification of cross-species metabolic biomarkers associated with type II diabetes. The study
describes sample collection of urine from mice, rats and human volunteers, and the subsequent acquisition of data
by high resolution 1H NMR spectroscopy. The metadata is described to demonstrate how the MSI descriptions
could be applied in a manuscript and the spectra have also been made available for the mouse and rat studies to
allow others to process the data.
Conclusions: The intention of this manuscript is to stimulate discussion as to whether the MSI description is
sufficient to describe the metadata associated with metabolomic experiments and encourage others to make their
data available to other researchers.
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Background
Metabolomics as a functional genomic tool is rapidly
growing in popularity for a range of applications across
all the kingdoms of life. This is both being driven and
driving developments in analytical chemistry, particu-
larly NMR spectroscopy and mass spectrometry, to
increase the capabilities of measuring metabolites in bio-
fluids, tissues, cell culture media and even whole organ-
isms. A diverse range of approaches are also applied
across metabolomics including open profiling
approaches aimed at detecting as wide a range of meta-
bolites as possible, commonly used in biomarker discov-
ery and functional genomic studies, or closed profiling
where metabolites of a given class are targeted, with this
approach being more amenable to quantification as well
as lending itself to hypothesis directed research.
However, one limiting factor for the future develop-
ment of metabolomics is data exchange. In a recent pro-
spective note two of the authors of this article observed:
“there is still a very small number of actual studies that
make their data available, and even fewer in a format
that would comply with the Metabolomics Standards
Initiative (MSI) description [1].” The MSI set out to
define the minimum information that is required to cap-
ture the necessary metadata to describe a metabolomic
experiment, in much the same way as initiatives such as
MIAME for microarrays and MIAPE for proteomics
[2-4]. In any such initiative there are obvious tensions
between the desire to completely describe an experiment
and still make the description user friendly to ensure
experimentalists will use it. The recommendations of
MSI produced a number of publications to describe this
minimum information [5-8].
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The aim of this report is to describe how one might
report this minimum metadata alongside the raw and
processed data of a previously published study. Our
aims are two-fold. Firstly, by demonstrating how this
data should be reported we hope to encourage others to
make their data available for the wider scientific com-
munity. Ultimately we hope to stimulate the creation of
dedicated databases for metabolomic data to allow
others to cross compare results from multiple studies.
This may in turn have significant savings financially
and, for mammalian work, reduce the total number of
animals required for future studies. An illustrative exam-
ple from our own area of research is in the use of meta-
bolomics as a functional genomic tool in obesity and
diabetes research. New mouse models which are
thought to suffer from diabetes are often compared with
results from known models, particularly the dbdb and
obob mouse strains where leptin signalling is impaired
[9,10]. Because there is no recognised database for meta-
bolomic data it is often necessary to include a cohort of
mice in the study of a known phenotype to cross-com-
pare with. This is both costly and animal intensive.
Metabolomic databases will allow the storage of pre-
vious results and ultimately allow comparison across
even more models. Secondly, by making the raw and
processed data available we also hope to aid bioinforma-
ticians involved in the development of new processing
and statistical tools.
The study we have chosen is a published study of two
rodent models of type II diabetes and human sufferers
of the disease [11]. For each species high resolution 1H
NMR spectroscopy was used to profile the metabolic
composition of urine, and then through a combination
of principal components analysis (PCA) and partial least
squares discriminate analysis (PLS-DA) metabolites dis-
tinct to each model and also common across all species
were identified.
Evidence of use
The metadata description is based on the descriptions
developed under MSI [5-8].
Metadata description
The publication Salek et al., 2007 [11] in fact consists of
three separate studies: two of rodent models of type II
diabetes and one study of human sufferers of type II
diabetes. Thus, to describe the metadata of the paper
there are three supplementary files dealing with the
description of the individual studies [Additional files 1,
2 and 3]. The format of the metadata follows the
description used by Fiehn and co-workers in [12] and
we thank Prof. Fiehn for making the Excel spreadsheet
available for use here. Considering the mouse data, the
metadata file starts by describing the animals, and in
particular what gene modification has been performed,
what tissue or biofluid is analyzed and how much mate-
rial is collected during the study. For strain and geno-
type of animals the recommendation is to use the
recognized convention if available for that species. For
mice we have used the strain description used by JAX
laboratories http://jaxmice.jax.org/strain/000642.html.
This is then followed by a brief description of the animal
housing, diet and water. Given the obvious impact diet has
on the metabolome it is particularly important to describe
this factor as the phenotype of a mouse model of diabetes
can vary markedly depending on whether the mice are on
a carbohydrate diet, as in this study, or on a high fat diet,
which increases the severity of many aspects of the meta-
bolic syndrome. This information is relatively straight for-
ward to collect for most laboratory animal studies but may
not be available for human studies or environmental stu-
dies where the subjects are free living. Under experimental
design the groups used for comparisons are described.
Most studies will have a relatively simple description of
animal numbers used in a study but for reference [11]
sample collection was performed on three genotypes, both
genders and either as part of 24 or 48 hr sample collec-
tions. As a result a supplementary table was required to
capture this information. Note also for the manuscript the
heterozygous and wildtype control mice were treated as a
single class and so the numbers are reported in the same
manner here.
Next, information is captured concerning sample
extraction. For a biofluid study this is relatively brief
and usually captures how the sample was diluted down,
but for tissues this part of the metadata would capture
what extraction procedure was used. In this study the
sample is diluted in phosphate buffer used to ensure the
pH is maintained at 7.2 and hence avoid shifts of key
resonances associated with the variability of pH of the
collected urine. The sample also has D2O added as a
lock reference, sodium azide as a preservative and
sodium 3-trimethylsilyl-(2,2,3,3-2H4)-1-propionate (TSP)
as a chemical shift reference.
No information is required in this study under chro-
matography, but information is then recorded for NMR
spectroscopy. This would be replaced by mass spectro-
metry descriptions if the study had used this particular
approach. For NMR spectroscopy it is particularly
important to capture information concerning the pulse
sequence used to acquire spectra. In the current study a
commonly used solvent suppression pulse sequence was
used, but for intact tissue and blood plasma/serum
markedly different results could be obtained depending
on whether the pulse sequence is edited for T1 or T2
relaxation or diffusion properties of the metabolites pre-
sent. Furthermore, the description of the pulse sequence
also allows the reader to judge whether the spectra are
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acquired under fully relaxed conditions or under semi-
saturated conditions which has important conse-
quences for subsequent quantification. In order for
people to complete the analysis performed in the
paper it is also necessary to report how the data was
subsequently processed both in terms of how the raw
data was converted into a format suitable for statistical
analysis, and how the subsequent statistical analysis is
performed. To allow others to re-create the analysis in
[11], as well as develop new tools for the processing of
NMR based metabolomic studies the supplementary
data include the original spectra for the mouse and rat
studies and the normalised integral files used in the
pattern recognition models [Additional files 4, 5, 6, 7,
8, 9 and 10]. For the normalised integral files the glu-
cose region has been excluded - this is because in the
original paper the aim was to identify potentially new
markers of type 2 diabetes, and not the obvious one of
increased glucose excretion! The excluded integral
regions were 3.22-3.30, 3.38-3.58, 3.70-3.94, 5.22-5.28
ppm [Additional files 1, 2, 4].
The deposition of NMR spectra raises the issue as to
what format spectra should be made available in.
Although JCAMP is a fairly uniformly accepted data
standard for NMR spectroscopy it is so rarely used and
most programs will readily process all vendor formats,
that we have chosen to use the vendor’s format - in this
case that used by Bruker BioSpin. Another issue is the
potential misuse of data which is made available to the
wider community. As the human data formed part of an
on-going series of drug trials we are not in a position to
make this data available to the wider community, and
thus any initiative to make data available in the metabo-
lomic community must consider that parts of the com-
munity may not be able to make all of their data
publically available.
This study involved both data from laboratory animals
and humans. The human study had a number of chal-
lenges to capture key metadata in terms of the study
design. While genotype was not an appropriate category
for a free living study where no sequencing data was
collected an important component of the study was the
inclusion and exclusion criteria of the patients. This has
been included as free text in the metadata.
One caveat with this report is the standards for meta-
bolomics are still evolving and although there are
descriptions of what is desired in a metadata description
of a metabolomics experiment, there is no consensus
across the community. However, only by beginning to
use the recommendations can experimentalists get a feel
for whether the descriptions capture enough or too
much information.
Carrots rather than sticks?
The biggest problem with data standards and making data
available to the community is the extra work required by
the experimentalist to make that data available. A descrip-
tion of the metadata involved in an experiment will always
take some extra time during the submission process of a
paper or a final report for a grant. One way to ensure
complicity is to go down the route of ‘sticks’ and mandate
scientists to submit data as part of the manuscript submis-
sion process, as occurs already for many microarray stu-
dies, or when a final report for a grant is submitted.
However, it’s also important to consider the carrots asso-
ciated with making data available. Firstly, it encourages
others to develop tools for the datasets that are deposited.
Secondly, it also encourages others to reference the work.
However, we feel the major carrot is the ability for groups
to work across multiple sites. If we consider metabolomics
in functional genomics, the ultimate aim is to understand
how the modification of every gene influences the metabo-
lism of the organism being studied. This is an immense
challenge that no one laboratory could hope to achieve.
The ability to develop databases for specific organisms and
disease processes will allow multiple labs to work together
and store their data alongside one another. These on-line
resources will become vital research tools for the commu-
nity in much the same way GenBank has supported gene
sequencing and the Gene Expression Omnibus (GEO) and
the Microarray Gene Expression Database (MGED) has
supported the microarray community.
Additional material
Additional file 1: Supplementary_data_human. Metadata associated
with the human diabetes study.
Additional file 2: Supplementary_data_mouse. Metadata associated
with dbdb mouse diabetes study.
Additional file 3: Supplementary_data_rat.
Additional file 4: Rar file containing all the spectra from the dbdb
mouse diabetes study in Bruker format.
Additional file 5: Rar file containing all the spectra from the Zucker
rat diabetes study in Bruker format.
Additional file 6: Rar file containing all the spectra from the Zucker
rat diabetes study in Bruker Format.
Additional file 7: Rar file containing all the spectra from the Zucker
rat diabetes study in Bruker format.
Additional file 8: Excel spread sheet containing normalised integral
files excluding the glucose region generated from the human
diabetes study.
Additional file 9: Excel spread sheet containing normalised integral
files excluding the glucose region generated from the dbdb mouse
diabetes study.
Additional file 10: Excel spread sheet containing normalised
integral files excluding the glucose region generated from the
Zucker rat diabetes study.
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